Anixa Biosciences Inc.

NASDAQ: ANIX · Real-Time Price · USD
2.97
0.00 (0.00%)
At close: Aug 15, 2025, 3:59 PM
2.97
0.00%
After-hours: Aug 15, 2025, 07:56 PM EDT

Anixa Biosciences Income Statement

Financials in USD. Fiscal year is November - October.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Oct 31, 2024 Oct 31, 2023 Oct 31, 2022 Oct 31, 2021
Revenue
n/a 210K 2.47B 512.5K
Cost of Revenue
n/a 161K 42K 385K
Gross Profit
n/a 49K 2.47B 127.5K
Operating Income
-13.83M -11.01M -13.88M -13.14M
Interest Income
1.13M 1.08M 104K 2.32K
Pretax Income
-12.55M -9.93M -13.77M -13.13M
Net Income
-12.55M -9.81M -13.49M -12.95M
Selling & General & Admin
7.43M 6.29M 7.17M 7.07M
Research & Development
6.4M 4.77M 6.7M 6.19M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
13.83M 11.06M 13.88M 13.26M
Interest Expense
n/a n/a 104K 322.00
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
13.83M 11.22M 13.88M 13.65M
Income Tax Expense
144K n/a n/a -181.29K
Shares Outstanding (Basic)
31.9M 30.98M 30.37M 28.58M
Shares Outstanding (Diluted)
31.9M 30.98M 30.37M 28.58M
EPS (Basic)
-0.39 -0.32 -0.44 -0.45
EPS (Diluted)
-0.39 -0.32 -0.44 -0.45
EBITDA
-12.66M -10.96M -13.73M -13.08M
EBIT
-12.7M -11.01M -13.77M -13.14M
Depreciation & Amortization
37K 46K 42K 59.86K